GSK announced that dosing has commenced in a phase III study evaluating sirukumab, a human anti-interleukin (IL)-6 monoclonal antibody, for the treatment of patients with giant cell arteritis (GCA).
GSK announced that dosing has commenced in a phase III study evaluating sirukumab, a human anti-interleukin (IL)-6 monoclonal antibody, for the treatment of patients with giant cell arteritis (GCA).
Takeda Pharmaceutical Company Limited announced that the multiple sclerosis treatment drug, "Copaxone® Subcutaneous Injection 20 mg Syringe" (generic name: glatiramer acetate, hereinafter "Copaxone") has become available in Japan.
Men with Type 2 diabetes who have low testosterone levels can benefit significantly from testosterone treatment, says a new study led by an Indian-American doctor.
Medicines do not appear to degrade faster in the zero-gravity atmosphere on the International Space Station (ISS) and this does not differ from what is typically seen on the Earth, researchers report.
Children who are left without direct parental care for extended periods of time show larger gray matter volumes in the brain and may also show delay in brain development, according to a new study.